ORANGE, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE CENTER FOR COMPREHENSIVE CARE AND DIAGNOSIS OF INHERITED BLOOD DISORDERS, founded in 2009, is a mid-sized nonprofit in the Health Care sector that reported $23.3M in total revenue in fiscal year 2023. Revenue grew 16% year-over-year, indicating healthy expansion. The organization ran a surplus of $6.4M, a strong 27% operating margin.
TO IMPROVE HEALTH AND LONGEVITY AND LOWER COSTS OF CARE; BY PROVIDING EDUCATION, SUPPORT, AND SERVICES TO DELIVER COMPREHENSIVE CARE FOR PATIENTS AND THEIR FAMILIES WITH RARE, CHRONIC INHERITED BLOOD DISORDERS.
THE CENTER FOR COMPREHENSIVE CARE AND DIAGNOSTICS OF INHERITED BLOOD DISORDERS (CIBD) IS A COMMUNITY BASED CLINIC THAT PROVIDES COMPREHENSIVE CARE FOR CHILDREN AND ADULTS WITH RARE, CHRONIC INHERITED...
THE CENTER FOR COMPREHENSIVE CARE AND DIAGNOSTICS OF INHERITED BLOOD DISORDERS (CIBD) IS A COMMUNITY BASED CLINIC THAT PROVIDES COMPREHENSIVE CARE FOR CHILDREN AND ADULTS WITH RARE, CHRONIC INHERITED BLOOD DISORDERS UTILIZING THE COMPREHENSIVE CARE MODEL. AS A SAFETY NET CLINIC, CIBD PROVIDES INCREASED ACCESS TO SUBSPECIALITY CARE THROUGH A MULTIDISCIPLINARY TEAM APPROACH. THROUGH PHARMACY SERVICES AND INNOVATIVE HEALTH INFORMATION TECHNOLOGY, CIBD IS ABLE TO EDUCATE PATIENTS AND FAMILIES AS WELL AS MONITOR AND DRIVE DOWN COST OF CARE THROUGH THE 340B PROGRAM.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $23,337,253 | $20,062,547 | +0.2% |
| Expenses | $16,931,546 | $18,826,320 | -0.1% |
| Net Income | $6,405,707 | $1,236,227 | +4.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DIANE J NUGENT MD | PRESIDENT/CHAIRPERSON | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| AMIT SONI MD | VICE PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARY BROWN | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| BERTIL GLADER MD PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RANDALL CURTIS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KATIE BIRSCHBACH | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BARRY STATON | CHIEF EXECUTIVE OFFICER & TREASURER | 40.00 |
Officer
|
$400,120 | $34,154 | $434,274 |
| MICHAEL WARDEN | CHIEF FINANCIAL OFFICER | 40.00 |
Officer
|
$255,018 | $29,547 | $284,565 |
| SAMANTHA CHAN | PHARMACY MANAGER | 40.00 |
Key Emp
|
$199,399 | $15,248 | $214,647 |
| JERALYN TUCKER | CLINIC MANAGER | 40.00 |
Key Emp
|
$151,355 | $14,116 | $165,471 |
| SHALINI VORA | GRANTS DIRECTOR | 40.00 |
Key Emp
|
$155,545 | $11,095 | $166,640 |
| NINA HWANG | PHYSICIAN | 32.00 |
Highest
|
$204,261 | $15,478 | $219,739 |
| MATTHEW CIANCIULLI | DIRECTOR OF CLINIC | 40.00 |
Highest
|
$199,987 | $15,141 | $215,128 |
| VANESSA SALINAS LUNA | PHYSICIAN | 40.00 |
Highest
|
$218,347 | $16,758 | $235,105 |
| ROBIN TAPPEY | HUMAN RESOURCES DIRECTOR | 40.00 |
Highest
|
$210,904 | $6,593 | $217,497 |
| ESTEBAN GOMEZ | PHYSICIAN | 32.00 |
Highest
|
$293,324 | $15,011 | $308,335 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $23,337,253 | $16,931,546 | $71,349,404 | $6,405,707 |
| 2023 | $20,062,547 | $18,826,320 | $61,282,179 | $1,236,227 |
| 2022 | $12,142,094 | $15,472,104 | $46,446,654 | $-3,330,010 |
| 2021 | $11,525,331 | $14,614,485 | $53,330,145 | $-3,089,154 |
| 2020 | $68,646,232 | $71,221,235 | $56,342,926 | $-2,575,003 |
| 2019 | $72,084,713 | $51,953,005 | $56,670,406 | $20,131,708 |
| 2018 | $61,281,622 | $40,887,659 | $35,584,652 | $20,393,963 |
Compare THE CENTER FOR COMPREHENSIVE CARE AND DIAGNOSIS OF INHERITED BLOOD DISORDERS with other nonprofits in California and across the country.